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Abstract Patients with classic galactosemia suffer from
several long term effects of their disease. Research in a group
of mainly female patients has shown that these patients may
also have a developmental delay with regard to their social
aptitude. To study if male galactosemia patients achieve
psychosocial developmental milestones more slowly than
male peers from the general Dutch population, we assessed
their development with the Course of Life Questionnaire
(CoLQ). A total of 18 male galactosemia patients participated
inthisstudy (response rate69%): 11Dutch patientsandseven
American patients. We found severe delays in the social and
psychosexual scales of this questionnaire, but not on the
autonomy axis. These results are comparable to an earlier
study with a limited number of male patients. The observed
delays could be secondary to less developed social skills,
cognitive dysfunction, or disrupted language development.
We strongly recommend screening of galactosemia patients
fordevelopmentaldelays,toensureearlyinterventionthrough
social skills training.
Introduction
Classic galactosemia (OMIM 230400) is an inherited disease
of carbohydrate metabolism caused by a mutation in the
Galactose-1-phosphate uridyltransferase (GALT) gene lead-
ing to a complete or near complete aberrance of GALT
activity. Its incidence in the Netherlands is about 1:33,000
(Bosch et al. 2005), in the US 1 in about 47,000 live born
children is affected (National Newborn Screening and
Genetics Research Center 2002). Despite dietary treatment
minimizing galactose intake, patients suffer from several
long term effects of their disease, such as primary ovarian
insufficiency, impaired mental abilities, decreased bone mass
and suboptimal growth (Holton et al. 2001). It is becoming
more and more clear that social problems may also be part of
the spectrum of these complications.
Children with chronic diseases are confronted with their
normal age-related development tasks, but must also learn
to live with their chronic illness or disability. Performing
developmental tasks is important for wellbeing and preven-
tion of adjustment problems later in life (Garber 1984;L e w i s
and Miller 1990). A chronic condition in childhood could
hamper the achievement of milestones, because the disease
can lead to an increased dependence on parents and reduced
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may be threatened, but also social development as a result of
the disease or treatment. A recent publication demonstrated
that the developmental trajectory of galactosemia patients is
hampered. When compared with both a healthy reference
group and a reference group of phenylketonuria patients they
achieved fewer psychosocial developmental milestones such
as participation in sports activities, going out and initiation
of intimate relationships (Bosch et al. 2009).
Women with galactosemia suffer from subfertility, but no
conclusive evidence on the male reproductive status in this
disease exists. There is a striking lack of published
fatherhood in these men, as to our knowledge only one
father was ever reported (Panis et al. 2006). We do know
that a few more galactosemic men have fathered a child
(personal communication European Galactosemia Society),
but there appears to be a discrepancy compared to the
numerous women that conceived. Our recent study has
shown that galactosemic men may face some fertility
challenges, although infertility is rare (unpublished data).
Young adults with chronic diseases face ongoing challenges
to negotiate and obtain normative psychosocial develop-
mental milestones and maintain adaptive functioning.
Galactosemics appear to reach their social milestones at a
slower pace than their peers, as was shown by Bosch and
colleagues (2009), but a limitation of this study was the
small number of male patients that took part in the study:
only three of the 15 patients were male.
To explore whether the percentage of male galactosemia
patients that has achieved psychosocial developmental
milestones was lower than the percentage among male
peers from the general Dutch population, we have assessed
their development with the Course of Life Questionnaire
(CoLQ) (Stam et al. 2005).
Methods
Patients
The studies were approved by the local IRB of the
participatinghospitals(MaastrichtUniversityMedical Center,
Amsterdam Medical Center and Children’s Hospital Boston)
as part of larger studies. Patients were invited to participate
through the Dutch Galactosemia Society (GVN) and Parents
of Galactosemic Children (PGC), and volunteered with
informed consent. Out of a total of 26 male galactosemia
patients that received the questionnaire, 18 participated in this
study (response rate 69%): 11 Dutch patients (eight from a
study in Maastricht, three other patients from an earlier study
in Amsterdam) and seven American patients. As the CoLQ is
validated only for patients aged 35 or younger, we included
only patients between 18 and 35. The reference group
introduced in an earlier study (Stam et al. 2005) was used
for comparison with our patients.
Course of life Questionnaire
The CoLQ was used to assess the achievement of
psychosocial developmental milestones retrospectively
(Stam et al. 2005). The CoLQ was developed in order to
be able to investigate the psychosocial developmental
milestones in young adults, who have grown up with a
chronic or life threatening disease, and to facilitate
comparison with that of peers without a history of disease.
The items, based on the literature and on clinical experi-
ence, concern behaviours that are characteristic for certain
age stages, developmental tasks, and the limitations
children might encounter when they grow up with a chronic
disease. Most questions ask retrospectively whether the
respondent had achieved certain psychosocial developmen-
tal milestones (yes, no) or at what age (category) the
respondent achieved the milestones. The answers are
dichotomised, if necessary, before being added up to the
scale-score. The items are divided into five domains: (1)
development of autonomy (6 items about autonomy at
home and outside the home), (2) psycho-sexual develop-
ment (4 items about love and sexual relations), (3) social
development (12 items about social contacts with peers, at
school and in leisure time), (4) anti-social behaviour (4
items about misbehaviour at school and outside school), (5)
substance use and gambling (12 items about the use of
alcohol, tobacco and drugs, and about gambling). Apart
from the five scales, the questionnaire measures socio-
demographic outcomes in young adulthood. The American
version of the CoLQ was established by a forwards-
backwards translation. The backwards translation was
cross-checked for inconsistencies by the authors of the
original. For some items cultural adaptation was accom-
plished (e.g. educational system).
The psychometric characteristics of the CoL-scales are
satisfactory, including validity (Stam et al. 2005). For this
study, only the items of the developmental scales
(autonomy development, psychosexual development and
social development) were taken into account since internal
consistency of sumscores in our small study sample was
limited. A reference group was recruited through general
practitioners in a former study (see Stam et al. (2005)f o r
details) and consisted of 508 respondents, 239 men (47.0%)
and 269 women (53.0%). The male data were used in the
current study.
Statistics
The Statistical Package for Social Sciences (SPSS) Windows
version16.0wasusedforalltheanalyses.Analysisofvariance
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Dutch galactosemia patients 11 18.1-26.6 22.8 2.8 11/14 (79%)
American galactosemia patients 7 21.4-35.0 26.4 5.2 7/12 (58%)
All galactosemia patients 18 18.1-35.0 24.2 4.2 18/26 (69%)
Reference group 239 18.0-30.9 24.0 3.9 –
Table 1 Characteristics of male
patients with galactosemia and
the reference group
Galactosemia Norm
% N % N Significance
1
Social development
At least one year competitive sports / sports club in elementary school
yes 50.0 9 87.8 209 < 0.001
no 50.0 9 12.2 29
Number of friends in kindergarten through third grade in elementary school
less than 4 83.3 15 31.6 75 < 0.001
4 or more 16.7 3 68.4 162
Number of friends in fourth-sixth grade in elementary school
less than 4 77.8 14 27.8 66 < 0.001
4 or more 22.2 4 72.2 171
Best friend in elementary school
yes 55.6 10 71.1 170 0.19
no 44.4 8 28.9 69
Most of time playing with ….. in elementary school
friends 38.9 7 87.2 204 < 0.001
brothers and/or sisters, parents, on your own 61.1 11 12.8 30
At least one year competitive sports in middle and/or high school
yes 33.3 6 76.9 183 < 0.001
no 66.7 12 23.1 55
Number of friends in middle and/or high school
less than 4 66.7 12 27.8 66 0.001
4 or more 33.3 6 72.2 171
Best friend in middle and/or high school
yes 44.4 8 65.4 155 0.081
no 55.6 10 34.6 82
Belonging to a group of friends in middle and/or high school
yes 44.4 8 78.4 185 0.003
no 55.6 10 21.6 51
Leisure time, mainly with ….. in middle and/or high school
friends 33.3 6 81.1 193 < 0.001
brothers and/or sisters, parents, on your own 66.7 12 18.9 45
Going to a bar or disco in middle and/or high school
sometimes / often 27.8 5 85.7 204 < 0.001
never 72.2 13 14.3 34
At least one year competitive sports / sports club after high school
yes 31.2 5 53.7 124 0.12
no 68.8 11 46.3 107
Table 2 Social milestones,
galactosemia versus reference
group
1 according to χ
2-test or Fisher’s
exact test
J Inherit Metab Dis (2011) 34:415–419 417revealed no age difference (at p<0.1) between the patient
groups and the reference group so that the analyses could be
performed without correction for age. Chi-square tests were
used to test differences between patients and the reference
group on the dichotomised items of the CoLQ (i.e. on the
proportion that achieved the milestone), using Fisher’se x a c t
testifthenumberofobservationsinthecellswasnotsufficient.
Because chi-square tests showed no considerable differences
between the CoL item scores of the Dutch and the American
patients, the Dutch and American patients were compared to
the reference population as one group. A significance level of
0.002 was used in order to compensate for multiple testing,
since we tested group differences on 23 milestones.
Results
Participants
The data on the patients and the reference group are
summarised in Table 1.
Psychosocial developmental milestones
Social development
Table 2 shows the milestones in the social development
scale. Patients with galactosemia scored significantly
(p<0.002) lower on 8 of the 12 milestones than the reference
group of peers from the general Dutch population. During
elementary school and during middle and/or high school, (1)
a lower percentage of galactosemia patients than of the
reference group reported competitive sports or membership
in a sports club for at least one year; (2) patients appeared to
have a lower number of friends than the reference group; (3)
they spent leisure time less often with friends than the
reference group did; and (4) patients went out to a bar or
disco less often than the reference group.
Psychosexual development and marital status
Patients with galactosemia scored significantly (p<0.002)
lower on all four milestones of psychosexual development
than the reference group of peers from the general Dutch
population (Table 3). The patients were older than the
reference group when they fell in love for the first time and
when they had their first boyfriend/girlfriend. They were
also older than the reference group at their first sexual
intimacy and first time of sexual intercourse. Only one of
the 18 galactosemic men was married. Although this
percentage is lower than that in the reference group this
difference did not reach significance.
Autonomy development
No significant differences (at p<0.002) were found on the
milestones of Autonomy development (details not shown).
These milestones concerned: regular chores/tasks in the
family, paid jobs, vacation without adults, leaving the
parents home.
Galactosemia Norm
% N % N Significance
1
Psychosexual development
First girlfriend / boyfriend
at the age of 17 or younger 29.4 5 77.7 185 < 0.001
at the age of 18 or older / never 70.6 12 22.3 53
For the first time falling in love
at the age of 18 or younger 58.8 10 91.1 215 0.001
at the age of 19 or older / never 41.2 7 8.9 21
For the first time sexual intimacy
at the age of 18 or younger 25.0 4 82.8 197 < 0.001
at the age of 19 or older / never 75.0 12 17.2 41
For the first time sexual intercourse
at the age of 18 or younger 17.6 3 55.9 133 0.002
at the age of 19 or older / never 82.4 14 44.1 105
Marital status
Married / living together 5.6 1 30.9 71 0.028
Single 94.4 17 69.1 159
Table 3 Psychosexual mile-
stones and marital status,
galactosemia versus reference
group
1 according to χ
2-test or Fisher’s
exact test
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This study shows a significant delay in both psychosexual
development as well as social development in young adult
men with galactosemia. These findings are comparable to
those seen in the whole group of galactosemia patients
(Bosch et al. 2009). The delay might in part explain the low
number of galactosemic fathers.
These findings indicate that it is important to encourage
children (boys) with galactosemia to make friends and to
participate in peer activities. Peer relationships are important
for social development and self-esteem, especially in adoles-
cents. Adolescents with chronic illnesses may become margin-
alised by peers, rejected for being different at a time when body
image and identity so largely depend on conformity (DiNapoli
and Murphy 2002). From previous research we know that
social development seemed to be related to psychosexual
development (Stam et al. 2005), so that friendships in youth
are probably important for later sexual relationships.
This study has some limitations. We included patients in
two different countries, whereas the reference group is from
the Netherlands only. The comparison between the Dutch and
the American patients, however, did not show any significant
difference (at p<0.01), so that comparison with the Dutch
reference group seemed justified. Another limitation is the
small sample size. As a result, we decided to include patients
up to 35 years while the reference group was aged up to
30 years. A strength of the study is that, compared to the total
number of known Dutch galactosemia patients, and the
number of American patients asked to participate, a relatively
large number of patients decided to enrol.
Future research is necessary to confirm the results of the
present, exploratory study, and to describe the relation
between developmental achievements and later adjustment.
The underlying reason behind the developmental delay in
galactosemic men perhaps could be found in social skills.
Generally, galactosemia patients are described as more
timid than their peers. Furthermore, cognitive dysfunction,
which is another complication of classic galactosemia, can
interfere with normal social and psychosexual development
as was described for childhood cancer survivors (Gurney et
al. 2009). This might make it more difficult for galacto-
semia patients to develop a healthy relationship and start a
family. The known problems with language development
might be another contributor to this problem.
Perhaps early intervention, such as the speech therapy
and social competence training (Last et al. 2007) that many
young galactosemia patients currently receive, could lead to
a better outcome for future generations. Furthermore,
currently therapeutic strategies aimed at preventing and
confining long term complications of classic galactosemia
are being developed. For physicians it is very important to
be aware of a possible delay in galactosemia patients, as it
could be important to address problems that may arise
during consultations. Paying attention to quality of life
during consultations using patient-reported outcomes could
be a valuable addition in clinical care (Engelen et al. 2010
(Epub ahead of print)).
In conclusion, men with classic galactosemia have
severe delays in social and psychosexual development, as
has been shown in a group of galactosemia patients of both
sexes before. We strongly support routine screening for
social and psycho-sexual development so that intervention
is possible at an early age.
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